Disease Info Card

Ventricular Arrhythmia

Information about Ventricular Arrhythmia: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Ventricular Arrhythmia

Most recent studies have shown that Ventricular Arrhythmia shares some biological mechanisms with cardiac-arrhythmia, cardiac-death, cardiac-fibrillation, cardiomyopathies, coronary-artery-disease, coronary-heart-disease, heart-diseases, heart-failure, infarction, ischemia, malignant-paraganglionic-neoplasm, myocardial-infarction, myocardial-ischemia, premature-cardiac-complex, premature-ventricular-contractions, sudden-cardiac-death, sudden-death, syncope, tachycardia-ventricular, ventricular-fibrillation.

Among the many pathways, these few ones have gauged particular interests from scientists studying Ventricular Arrhythmia, and have been seen in publications frequently: Aging, Anaphylaxis, Angiogenesis, Cardiac Conduction, Circadian Rhythm, Coagulation, Excretion, Hemostasis, Hypersensitivity, Inflammatory Response, Innervation, Localization, Pathogenesis, Platelet Aggregation, Reflex, Secretion, Transport, Transposition, Vasoconstriction, Vasodilation

Quite a number of genes have been found to play important roles in Ventricular Arrhythmia, such as ACE, COX5A, CYP3A4, GJA1, GNL3, KCNH2, KCNQ1, KRAS, MITF, PGR, RANGAP1, SCD, SCN5A, SERPINA5, SLC17A5, TMEM37, UBN1. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.